Co-Authors
This is a "connection" page, showing publications co-authored by Shan-Chwen Chang and Szu-Min Hsieh.
Connection Strength
1.675
-
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC-COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study. EClinicalMedicine. 2021 Aug; 38:100989.
Score: 0.953
-
Dose-Related Aberrant Inhibition of Intracellular Perforin Expression by S1 Subunit of Spike Glycoprotein That Contains Receptor-Binding Domain from SARS-CoV-2. Microorganisms. 2021 Jun 15; 9(6).
Score: 0.238
-
Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19. J Formos Med Assoc. 2021 Dec; 120(12):2186-2190.
Score: 0.235
-
A cross-sectional seroprevalence for COVID-19 among healthcare workers in a tertially care hospital in Taiwan. J Formos Med Assoc. 2021 Jul; 120(7):1459-1463.
Score: 0.231
-
Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerg Infect Dis. 2004 Jul; 10(7):1213-9.
Score: 0.018